bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table S1-S2 from 5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis
Authors: Jin Sha , Cojocari Dan , Purkal Julie J. , Popovic Relja , Talaty Nari N. , Xiao Yu , Solomon Larry R. , Boghaert Erwin R. , Leverson Joel D. , Phillips Darren C.
Published: April 2023

Supplementary Table
Table S1 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
Authors: Mendez Flor , Kadiyala Padma , Nunez Felipe J. , Carney Stephen , Nunez Fernando M. , Gauss Jessica C. , Ravindran Ramya , Pawar Sheeba , Edwards Marta , Garcia-Fabiani Maria Belen , Haase Santiago , Lowenstein Pedro R. , Castro Maria G.
Published: April 2023

Table of antibodies used
Figure S6 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
Authors: Mendez Flor , Kadiyala Padma , Nunez Felipe J. , Carney Stephen , Nunez Fernando M. , Gauss Jessica C. , Ravindran Ramya , Pawar Sheeba , Edwards Marta , Garcia-Fabiani Maria Belen , Haase Santiago , Lowenstein Pedro R. , Castro Maria G.
Published: April 2023

Gating Strategy used in Figure 6
Figure S5 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
Authors: Mendez Flor , Kadiyala Padma , Nunez Felipe J. , Carney Stephen , Nunez Fernando M. , Gauss Jessica C. , Ravindran Ramya , Pawar Sheeba , Edwards Marta , Garcia-Fabiani Maria Belen , Haase Santiago , Lowenstein Pedro R. , Castro Maria G.
Published: April 2023

Experimental Validation of Figure 5C
Supplementary Table 5 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Authors: Laurent Anouchka P. , Siret Aurélie , Ignacimouttou Cathy , Panchal Kunjal , Diop M'Boyba , Jenni Silvia , Tsai Yi-Chien , Roos-Weil Damien , Aid Zakia , Prade Nais , Lagarde Stephanie , Plassard Damien , Pierron Gaelle , Daudigeos Estelle , Lecluse Yann , Droin Nathalie , Bornhauser Beat C. , Cheung Laurence C. , Crispino John D. , Gaudry Muriel , Bernard Olivier A. , Macintyre Elizabeth , Barin Bonnigal Carole , Kotecha Rishi S. , Geoerger Birgit , Ballerini Paola , Bourquin Jean-Pierre , Delabesse Eric , Mercher Thomas , Malinge Sebastien
Published: April 2023

Differentially expressed genes in murine B cell precursors
Supplementary Table 4 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Authors: Laurent Anouchka P. , Siret Aurélie , Ignacimouttou Cathy , Panchal Kunjal , Diop M'Boyba , Jenni Silvia , Tsai Yi-Chien , Roos-Weil Damien , Aid Zakia , Prade Nais , Lagarde Stephanie , Plassard Damien , Pierron Gaelle , Daudigeos Estelle , Lecluse Yann , Droin Nathalie , Bornhauser Beat C. , Cheung Laurence C. , Crispino John D. , Gaudry Muriel , Bernard Olivier A. , Macintyre Elizabeth , Barin Bonnigal Carole , Kotecha Rishi S. , Geoerger Birgit , Ballerini Paola , Bourquin Jean-Pierre , Delabesse Eric , Mercher Thomas , Malinge Sebastien
Published: April 2023

List of fusion transcripts identified through RNA-sequencing
Supplementary Table 3 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Authors: Laurent Anouchka P. , Siret Aurélie , Ignacimouttou Cathy , Panchal Kunjal , Diop M'Boyba , Jenni Silvia , Tsai Yi-Chien , Roos-Weil Damien , Aid Zakia , Prade Nais , Lagarde Stephanie , Plassard Damien , Pierron Gaelle , Daudigeos Estelle , Lecluse Yann , Droin Nathalie , Bornhauser Beat C. , Cheung Laurence C. , Crispino John D. , Gaudry Muriel , Bernard Olivier A. , Macintyre Elizabeth , Barin Bonnigal Carole , Kotecha Rishi S. , Geoerger Birgit , Ballerini Paola , Bourquin Jean-Pierre , Delabesse Eric , Mercher Thomas , Malinge Sebastien
Published: April 2023

List of the SNVs identified through RNA-sequencing
Figure S3 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
Authors: Mendez Flor , Kadiyala Padma , Nunez Felipe J. , Carney Stephen , Nunez Fernando M. , Gauss Jessica C. , Ravindran Ramya , Pawar Sheeba , Edwards Marta , Garcia-Fabiani Maria Belen , Haase Santiago , Lowenstein Pedro R. , Castro Maria G.
Published: April 2023

Western Blot of Smad1/5 signaling in tumor NS
Supplementary Table 1 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Authors: Laurent Anouchka P. , Siret Aurélie , Ignacimouttou Cathy , Panchal Kunjal , Diop M'Boyba , Jenni Silvia , Tsai Yi-Chien , Roos-Weil Damien , Aid Zakia , Prade Nais , Lagarde Stephanie , Plassard Damien , Pierron Gaelle , Daudigeos Estelle , Lecluse Yann , Droin Nathalie , Bornhauser Beat C. , Cheung Laurence C. , Crispino John D. , Gaudry Muriel , Bernard Olivier A. , Macintyre Elizabeth , Barin Bonnigal Carole , Kotecha Rishi S. , Geoerger Birgit , Ballerini Paola , Bourquin Jean-Pierre , Delabesse Eric , Mercher Thomas , Malinge Sebastien
Published: April 2023

Characteristics of the B-ALL cohort
Supplementary Data from Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
Authors: Krämer Pauline , Talhouk Aline , Brett Mary Anne , Chiu Derek S. , Cairns Evan S. , Scheunhage Daniëlla A. , Hammond Rory F.L. , Farnell David , Nazeran Tayyebeh M. , Grube Marcel , Xia Zhouchunyang , Senz Janine , Leung Samuel , Feil Lukas , Pasternak Jana , Dixon Katherine , Hartkopf Andreas , Krämer Bernhard , Brucker Sara , Heitz Florian , du Bois Andreas , Harter Philipp , Kommoss Felix K.F. , Sinn Hans-Peter , Heublein Sabine , Kommoss Friedrich , Vollert Hans-Walter , Manchanda Ranjit , de Kroon Cornelis D. , Nijman Hans W. , de Bruyn Marco , Thompson Emily F. , Bashashati Ali , McAlpine Jessica N. , Singh Naveena , Tinker Anna V. , Staebler Annette , Bosse Tjalling , Kommoss Stefan , Köbel Martin , Anglesio Michael S.
Published: April 2023

Package with all supplemental figures and tables
Figure S4 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Authors: Laurent Anouchka P. , Siret Aurélie , Ignacimouttou Cathy , Panchal Kunjal , Diop M'Boyba , Jenni Silvia , Tsai Yi-Chien , Roos-Weil Damien , Aid Zakia , Prade Nais , Lagarde Stephanie , Plassard Damien , Pierron Gaelle , Daudigeos Estelle , Lecluse Yann , Droin Nathalie , Bornhauser Beat C. , Cheung Laurence C. , Crispino John D. , Gaudry Muriel , Bernard Olivier A. , Macintyre Elizabeth , Barin Bonnigal Carole , Kotecha Rishi S. , Geoerger Birgit , Ballerini Paola , Bourquin Jean-Pierre , Delabesse Eric , Mercher Thomas , Malinge Sebastien
Published: April 2023

Enrichment of the 281 commonly deregulated genes in human and murine B cell precursors
Figure S3 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Authors: Laurent Anouchka P. , Siret Aurélie , Ignacimouttou Cathy , Panchal Kunjal , Diop M'Boyba , Jenni Silvia , Tsai Yi-Chien , Roos-Weil Damien , Aid Zakia , Prade Nais , Lagarde Stephanie , Plassard Damien , Pierron Gaelle , Daudigeos Estelle , Lecluse Yann , Droin Nathalie , Bornhauser Beat C. , Cheung Laurence C. , Crispino John D. , Gaudry Muriel , Bernard Olivier A. , Macintyre Elizabeth , Barin Bonnigal Carole , Kotecha Rishi S. , Geoerger Birgit , Ballerini Paola , Bourquin Jean-Pierre , Delabesse Eric , Mercher Thomas , Malinge Sebastien
Published: April 2023

Selected datasets of GSEA between paired comparisons
Supplementary Data from Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology
Authors: Ye Zezhong , Price Richard L. , Liu Xiran , Lin Joshua , Yang Qingsong , Sun Peng , Wu Anthony T. , Wang Liang , Han Rowland H. , Song Chunyu , Yang Ruimeng , Gary Sam E. , Mao Diane D. , Wallendorf Michael , Campian Jian L. , Li Jr-Shin , Dahiya Sonika , Kim Albert H. , Song Sheng-Kwei
Published: April 2023

Supplementary methods, figures and tables
Figure S2 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Authors: Laurent Anouchka P. , Siret Aurélie , Ignacimouttou Cathy , Panchal Kunjal , Diop M'Boyba , Jenni Silvia , Tsai Yi-Chien , Roos-Weil Damien , Aid Zakia , Prade Nais , Lagarde Stephanie , Plassard Damien , Pierron Gaelle , Daudigeos Estelle , Lecluse Yann , Droin Nathalie , Bornhauser Beat C. , Cheung Laurence C. , Crispino John D. , Gaudry Muriel , Bernard Olivier A. , Macintyre Elizabeth , Barin Bonnigal Carole , Kotecha Rishi S. , Geoerger Birgit , Ballerini Paola , Bourquin Jean-Pierre , Delabesse Eric , Mercher Thomas , Malinge Sebastien
Published: April 2023

Oncogenic cooperation between RAS/MAPK activation and gain of chromosome 21 in murine and human B cell precursors
Supplemental Appendix 1, Supplementary Tables 1-5 from Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas
Authors: Boal Lauren H. , Glod John , Spencer Melissa , Kasai Miki , Derdak Joanne , Dombi Eva , Ahlman Mark , Beury Daniel W. , Merchant Melinda S. , Persenaire Christianne , Liewehr David J. , Steinberg Seth M. , Widemann Brigitte C. , Kaplan Rosandra N.
Published: April 2023

Supplemental appendix and tables
Supplementary Table S1: FDA Capillary Leak Syndrome Screening Criteria from FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Authors: Jen Emily Y. , Gao Xin , Li Liang , Zhuang Luning , Simpson Natalie E. , Aryal Baikuntha , Wang Rong , Przepiorka Donna , Shen Yuan Li , Leong Ruby , Liu Chao , Sheth Christopher M. , Bowen Steven , Goldberg Kirsten B. , Farrell Ann T. , Blumenthal Gideon M. , Pazdur Richard
Published: April 2023

Supplementary Table 1 contains FDA's screening algorithm for capillary leak syndrome (CLS).
Supplementary Data from Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During Radiochemotherapy
Authors: Goerig Nicole L. , Frey Benjamin , Korn Klaus , Fleckenstein Bernhard , Überla Klaus , Schmidt Manuel A. , Dörfler Arnd , Engelhorn Tobias , Eyüpoglu Ilker , Rühle Paul F. , Putz Florian , Semrau Sabine , Gaipl Udo S. , Fietkau Rainer
Published: April 2023

Supplementary Table 1
Supplementary Data 1 from A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial
Authors: Kloor Matthias , Reuschenbach Miriam , Pauligk Claudia , Karbach Julia , Rafiyan Mohammad-Reza , Al-Batran Salah-Eddin , Tariverdian Mirjam , Jäger Elke , von Knebel Doeberitz Magnus
Published: April 2023

Intention to Treat Data
eTable 3 from Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials
Authors: Stahler Arndt , Stintzing Sebastian , Modest Dominik P. , Ricard Ingrid , Giessen-Jung Clemens , Kapaun Christine , Ivanova Boryana , Kaiser Florian , Fischer von Weikersthal Ludwig , Moosmann Nicolas , Schalhorn Andreas , Stauch Martina , Kiani Alexander , Held Swantje , Decker Thomas , Moehler Markus , Neumann Jens , Kirchner Thomas , Jung Andreas , Heinemann Volker
Published: April 2023

Outcome according to high vs. low unnormalized AREG expression in all patients and subgroups
Supplementary Data from A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer
Authors: Krop Ian , Abramson Vandana , Colleoni Marco , Traina Tiffany , Holmes Frankie , Garcia-Estevez Laura , Hart Lowell , Awada Ahmad , Zamagni Claudio , Morris Patrick G. , Schwartzberg Lee , Chan Stephen , Gucalp Ayca , Biganzoli Laura , Steinberg Joyce , Sica Lorenzo , Trudeau Maureen , Markova Denka , Tarazi Jamal , Zhu Zhou , O'Brien Thomas , Kelly Catherine M. , Winer Eric , Yardley Denise A.
Published: April 2023

Protocol 12 Supplement File
Supplementary Figure 6 from ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor–Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials
Authors: Turner Nicholas C. , Swift Claire , Kilburn Lucy , Fribbens Charlotte , Beaney Matthew , Garcia-Murillas Isaac , Budzar Aman U. , Robertson John F.R. , Gradishar William , Piccart Martine , Schiavon Gaia , Bliss Judith M. , Dowsett Mitch , Johnston Stephen R.D. , Chia Stephen K.
Published: April 2023

Supplementary Figure 6. Progression free survival in monoclonal and polyclonal ESR1 mutations
eFigure 1 from Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials
Authors: Stahler Arndt , Stintzing Sebastian , Modest Dominik P. , Ricard Ingrid , Giessen-Jung Clemens , Kapaun Christine , Ivanova Boryana , Kaiser Florian , Fischer von Weikersthal Ludwig , Moosmann Nicolas , Schalhorn Andreas , Stauch Martina , Kiani Alexander , Held Swantje , Decker Thomas , Moehler Markus , Neumann Jens , Kirchner Thomas , Jung Andreas , Heinemann Volker
Published: April 2023

Staining intensities of immunohistochemial EGFR expression, A: weak staining intensity (+1); B: moderate staining intensity (+2); C: strong staining intensity (+3). A score containing the percentage of stained cells (0 - 100 %) multiplied with staining intensity (+1 to +3) was generated, a threshold value of 22.5 score points was established previously to distinguish EGFR positive and negative tumors.
Supplementary Figure 3 from ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor–Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials
Authors: Turner Nicholas C. , Swift Claire , Kilburn Lucy , Fribbens Charlotte , Beaney Matthew , Garcia-Murillas Isaac , Budzar Aman U. , Robertson John F.R. , Gradishar William , Piccart Martine , Schiavon Gaia , Bliss Judith M. , Dowsett Mitch , Johnston Stephen R.D. , Chia Stephen K.
Published: April 2023

Supplementary Figure 3. Time To Progression in EFECT by detection of ESR1 mutations in baseline serum
Supplementary Tables 1-22 from Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
Authors: Koga Yusuke , Song Hanbing , Chalmers Zachary R. , Newberg Justin , Kim Eejung , Carrot-Zhang Jian , Piou Daphnee , Polak Paz , Abdulkadir Sarki A. , Ziv Elad , Meyerson Matthew , Frampton Garrett M. , Campbell Joshua D. , Huang Franklin W.
Published: April 2023

All supplementary tables
Supplementary Legends from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling
Authors: Zugazagoitia Jon , Gupta Swati , Liu Yuting , Fuhrman Kit , Gettinger Scott , Herbst Roy S. , Schalper Kurt A. , Rimm David L.
Published: April 2023

Supplementary Legends
Supplementary Figures from Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
Authors: Koga Yusuke , Song Hanbing , Chalmers Zachary R. , Newberg Justin , Kim Eejung , Carrot-Zhang Jian , Piou Daphnee , Polak Paz , Abdulkadir Sarki A. , Ziv Elad , Meyerson Matthew , Frampton Garrett M. , Campbell Joshua D. , Huang Franklin W.
Published: April 2023

All supplementary figures
Supplementary Figure S6 from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling
Authors: Zugazagoitia Jon , Gupta Swati , Liu Yuting , Fuhrman Kit , Gettinger Scott , Herbst Roy S. , Schalper Kurt A. , Rimm David L.
Published: April 2023

Histogram showing CD3 counts (A) and CD8 counts (B) in the CD45 compartment (blue) and non-immune cells stromal compartment (orange) on each NSCLC case
Supplementary Figure S5 from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling
Authors: Zugazagoitia Jon , Gupta Swati , Liu Yuting , Fuhrman Kit , Gettinger Scott , Herbst Roy S. , Schalper Kurt A. , Rimm David L.
Published: April 2023

Representative cases that were unevaluable for CD45/CD68-related discoveries due to small area/absence of CD45/CD68 compartments (scale bar = 100 ï�­m)
Figure S1 from Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
Authors: Koga Yusuke , Song Hanbing , Chalmers Zachary R. , Newberg Justin , Kim Eejung , Carrot-Zhang Jian , Piou Daphnee , Polak Paz , Abdulkadir Sarki A. , Ziv Elad , Meyerson Matthew , Frampton Garrett M. , Campbell Joshua D. , Huang Franklin W.
Published: April 2023

Associations of recurrent deletion events of selected genes with Gleason score and race in TCGA and AAPC cohorts. Left: Amplification frequencies were associated with race and Gleason score while controlling for age using samples from TCGA and AAPC cohorts with genome-wide copy number ratio data (AFR: 157, EUR: 392). A purple dot indicates statistically significant association with race (FDR < 0.05). The solid black line represents a 1:1 relationship between AFR and EUR patients. Genes that did not have a significant association (FDR >= 0.05) with race are indicated by an open dot. Right: Deletion frequencies for PTEN, ZFHX3, and ETV3 are shown in AFR and EUR men.
Supplementary Data from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling
Authors: Zugazagoitia Jon , Gupta Swati , Liu Yuting , Fuhrman Kit , Gettinger Scott , Herbst Roy S. , Schalper Kurt A. , Rimm David L.
Published: April 2023

Supplementary methods and tables S1-S4
Supplementary Data from Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab
Authors: Hopkins Ashley M. , Kichenadasse Ganessan , Karapetis Christos S. , Rowland Andrew , Sorich Michael J.
Published: April 2023

Supplementary Results
Supplementary Data from Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs
Authors: Cobleigh Melody , Yardley Denise A. , Brufsky Adam M. , Rugo Hope S. , Swain Sandra M. , Kaufman Peter A. , Tripathy Debu , Hurvitz Sara A. , O'Shaughnessy Joyce , Mason Ginny , Antao Vincent , Li Haocheng , Chu Laura , Jahanzeb Mohammad
Published: April 2023

Supplemental Table 1. Baseline demographics, patient characteristics, and disease characteristics by percentage HR positivity; Supplemental Table 2. HR status concordance rates in primary vs. metastatic tumors in patients with (A) HR-positive disease (n=685), (B) low HR positivity (1%-9%, n=60), and (C) moderate/high HR positivity (10%-100%, n=550); Supplemental Table 3. First-line systemic treatment by percentage HR positivity in patients with HR-positive, HER2-positive MBC; Supplemental Table 4. First-line systemic treatment by HR status and de novo vs. recurrent disease in patients with HER2-positive MBC; Supplemental Figure 1. Distribution of patients with HR-positive, HER2-positive MBC by level of HR expression; Supplemental Figure 2. Association between baseline patient and disease characteristics and overall survival in patients with HER2-positive MBC; Supplemental Figure 3. Overall survival by HR status and age in patients with HER2-positive MBC; Supplemental Figure 4. Overall survival by HR status and race in patients with HER2-positive MBC
Supplementary Methods from STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1
Authors: Proia Theresa A. , Singh Maneesh , Woessner Richard , Carnevalli Larissa , Bommakanti Gayathri , Magiera Lukasz , Srinivasan Srimathi , Grosskurth Shaun , Collins Mike , Womack Chris , Griffin Matthew , Ye Minwei , Cantin Susan , Russell Deanna , Xie Mingchao , Hughes Adina , Deng Nanhua , Mele Deanna A. , Fawell Stephen , Barry Simon , Reimer Corinne , Barrett J. Carl , McCoon Patricia
Published: April 2023

Gating and antibodies for flow cytometry and CyTOF
Figure S2 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial
Authors: Tang Bixia , Chi Zhihong , Chen Yingbo , Liu Xiufeng , Wu Di , Chen Jing , Song Xin , Wang Weifeng , Dong Lihou , Song Haifeng , Wu Hai , Feng Hui , Yao Sheng , Qin Shuikui , Zhang Xiaoshi , Guo Jun
Published: April 2023

Progression-free survival (A) and overall survival (B) of melanoma subtypes in the study. Percentages of survival patients are shown at indicated time points. Censored patients are marked with "â"ƒ" in the graph. Numbers of patients at risk at indicated time points are shown below the x-axis.
Supplementary Figures 10 and 11 from STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1
Authors: Proia Theresa A. , Singh Maneesh , Woessner Richard , Carnevalli Larissa , Bommakanti Gayathri , Magiera Lukasz , Srinivasan Srimathi , Grosskurth Shaun , Collins Mike , Womack Chris , Griffin Matthew , Ye Minwei , Cantin Susan , Russell Deanna , Xie Mingchao , Hughes Adina , Deng Nanhua , Mele Deanna A. , Fawell Stephen , Barry Simon , Reimer Corinne , Barrett J. Carl , McCoon Patricia
Published: April 2023

Cytokine, T, and NK cell changes in CT26 tumors
Supplementary Results from Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab
Authors: Hopkins Ashley M. , Kichenadasse Ganessan , Garrett-Mayer Elizabeth , Karapetis Christos S. , Rowland Andrew , Sorich Michael J.
Published: April 2023

Supplementary result table and figures
Supplementary TABLE 4 from Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Authors: Merz Valeria , Zecchetto Camilla , Santoro Raffaela , Simionato Francesca , Sabbadini Fabio , Mangiameli Domenico , Piro Geny , Cavaliere Alessandro , Deiana Michela , Valenti Maria Teresa , Bazan Diana , Fedele Vita , Lonardi Sara , Melisi Davide
Published: April 2023

Supplementary TABLE 4
Supplementary Table S1 from X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis
Authors: Tricarico Rossella , Nicolas Emmanuelle , Hall Michael J. , Golemis Erica A.
Published: April 2023

Frequency of KDM6A, UTY, KDM5C and KDM5D genetic alterations in cancers with sex-biased and unbiased incidence
Supplementary TABLE 1 from Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Authors: Merz Valeria , Zecchetto Camilla , Santoro Raffaela , Simionato Francesca , Sabbadini Fabio , Mangiameli Domenico , Piro Geny , Cavaliere Alessandro , Deiana Michela , Valenti Maria Teresa , Bazan Diana , Fedele Vita , Lonardi Sara , Melisi Davide
Published: April 2023

Supplementary TABLE 1
Figure S8. from Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Authors: Merz Valeria , Zecchetto Camilla , Santoro Raffaela , Simionato Francesca , Sabbadini Fabio , Mangiameli Domenico , Piro Geny , Cavaliere Alessandro , Deiana Michela , Valenti Maria Teresa , Bazan Diana , Fedele Vita , Lonardi Sara , Melisi Davide
Published: April 2023

Kaplan-Meier curves of overall survival stratifying patients in the discovery cohort for a significant cut-off value of eotaxin (A), GM-CSF (B), Gro-alpha (C), IL-12p70 (D), IL-13 (E), IL-18 (F), IL-1 beta (G), IL-2 (H), IL-4 (I), IL-5 (J), IL-6 (K), IFN gamma (L), IP-10 (M), MCP-1 (N), MIP-1alpha (O), MIP-1 beta(P), RANTES (Q), SDF-1alpha (R) and TNF-alpha (S).
Figure S7. from Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Authors: Merz Valeria , Zecchetto Camilla , Santoro Raffaela , Simionato Francesca , Sabbadini Fabio , Mangiameli Domenico , Piro Geny , Cavaliere Alessandro , Deiana Michela , Valenti Maria Teresa , Bazan Diana , Fedele Vita , Lonardi Sara , Melisi Davide
Published: April 2023

The histograms report the relative frequency for each cytokine value and the distribution of values compared to the cut-off calculated for progression-free survival of patients in the discovery cohort. The histograms are referred to eotaxin (A), GM-CSF (B), Gro-alpha (C), IL-12p70 (D), IL-13 (E), IL-18 (F), IL-1 beta (G), IL-2 (H), IL-4 (I), IL-5 (J), IL-6 (K), IFN gamma (L), IP-10 (M), MCP-1 (N), MIP-1alpha (O), MIP-1 beta(P), RANTES (Q), SDF-1alpha (R) and TNF-alpha (S).
Figure S4. from Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Authors: Merz Valeria , Zecchetto Camilla , Santoro Raffaela , Simionato Francesca , Sabbadini Fabio , Mangiameli Domenico , Piro Geny , Cavaliere Alessandro , Deiana Michela , Valenti Maria Teresa , Bazan Diana , Fedele Vita , Lonardi Sara , Melisi Davide
Published: April 2023

Kaplan-Meier curves of progression-free survival stratifying patients in the discovery cohort for a significant cut-off value of eotaxin (A), GM-CSF (B), Gro-alpha (C), IL-12p70 (D), IL-13 (E), IL-18 (F), IL-1 beta (G), IL-2 (H), IL-4 (I), IL-5 (J), IL-6 (K), IFN gamma (L), IP-10 (M), MCP-1 (N), MIP-1alpha (O), MIP-1 beta(P), RANTES (Q), SDF-1alpha (R) and TNF-alpha (S).
Figure S3. from Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Authors: Merz Valeria , Zecchetto Camilla , Santoro Raffaela , Simionato Francesca , Sabbadini Fabio , Mangiameli Domenico , Piro Geny , Cavaliere Alessandro , Deiana Michela , Valenti Maria Teresa , Bazan Diana , Fedele Vita , Lonardi Sara , Melisi Davide
Published: April 2023

The hazard ratios (HRs) with 95% CI are shown in dependence of possible cutoff points of IL-8 for median progression-free survival (mPFS) (A) and overall survival (mOS) (D) durations of patients in the discovery cohort. The differences in mean survival times are estimated for each IL-8 value for mPFS (B) and mOS (E). The histogram shows the relative frequency of each IL-8 value for mPFS (C) and mOS (F). The optimal cutoff is marked by a vertical line.
Supplementary Data files S1 a_f from Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy
Authors: Carrato Cristina , Alameda Francesc , Esteve-Codina Anna , Pineda Estela , Arpí Oriol , Martinez-García Maria , Mallo Mar , Gut Marta , Lopez-Martos Raquel , Barco Sonia Del , Ribalta Teresa , Capellades Jaume , Puig Josep , Gallego Oscar , Mesia Carlos , Muñoz-Marmol Ana M , Archilla Ivan , Arumí Montserrat , Blanc Julie Marie , Bellosillo Beatriz , Menendez Silvia , Esteve Anna , Bagué Silvia , Hernandez Ainhoa , Craven-Bartle Jordi , Fuentes Rafael , Vidal Noemí , Aldecoa Iban , Iglesia Nuria de la , Balana Carmen
Published: April 2023

Excel spreadsheets showing: (S1a) the differential expression analysis between mesenchymal vs proneural tumors; (S1b) the differential expression analysis between classical vs mesenchymal tumors; (S1c) the differential expression analysis between classical vs proneural tumors; (S1d) classification of tumor samples based on the RNA-Seq results into the three TCGA molecular subtypes (according to the GlioVis algorithms KNN, SVM, and ssGSEA) and classification according to the IGS clusters; (S1e) immunohistochemical results of samples classified in the three TCGA molecular subtypes (according to the GlioVis algorithms KNN, SVM, and ssGSEA) and IGS clusters; and (S1f) results of the gene fusion analysis in the tumor samples, the molecular subtype of the tumor (according to the GlioVis algorithms KNN, SVM, and ssGSEA), and the tumor IGS clusters
Supplementary figures from Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
Authors: Meel Michaël H. , de Gooijer Mark C. , Metselaar Dennis S. , Sewing A. Charlotte P. , Zwaan Kenn , Waranecki Piotr , Breur Marjolein , Buil Levi C.M. , Lagerweij Tonny , Wedekind Laurine E. , Twisk Jos W.R. , Koster Jan , Hashizume Rintaro , Raabe Eric H. , Montero Carcaboso Ángel , Bugiani Marianna , Phoenix Timothy N. , van Tellingen Olaf , van Vuurden Dannis G. , Kaspers Gertjan J.L. , Hulleman Esther
Published: April 2023

File containing all supplementary figures
Appendix A from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial
Authors: Sarker Debashis , Plummer Ruth , Meyer Tim , Sodergren Mikael H. , Basu Bristi , Chee Cheng Ean , Huang Kai-Wen , Palmer Daniel H. , Ma Yuk Ting , Evans T.R. Jeff , Spalding Duncan R.C. , Pai Madhava , Sharma Rohini , Pinato David J. , Spicer James , Hunter Sarah , Kwatra Vineet , Nicholls Joanna P. , Collin David , Nutbrown Robert , Glenny Helen , Fairbairn Sonia , Reebye Vikash , Voutila Jon , Dorman Stephanie , Andrikakou Pinelopi , Lloyd Peter , Felstead Steve , Vasara Jenni , Habib Robert , Wood Chris , Saetrom Pal , Huber Hans E. , Blakey David C. , Rossi John J. , Habib Nagy
Published: April 2023

Trial Protocol
Supplementary Data from Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors
Authors: Trendowski Matthew R. , Wheeler Heather E. , El-Charif Omar , Feldman Darren R. , Hamilton Robert J. , Vaughn David J. , Fung Chunkit , Kollmannsberger Christian , Einhorn Lawrence H. , Travis Lois B. , Dolan M. Eileen
Published: April 2023

The design of the study, GWAS results, clinical characteristics are included in the supplemental data.
Supplementary Table S3 from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Authors: Autio Karen A. , Klebanoff Christopher A. , Schaer David , Kauh John Sae Wook , Slovin Susan F. , Adamow Matthew , Blinder Victoria S. , Brahmachary Manisha , Carlsen Michelle , Comen Elizabeth , Danila Daniel C. , Doman Thompson N. , Durack Jeremy C. , Fox Josef J. , Gluskin Jill S. , Hoffman David M. , Kang Suhyun , Kang Praneet , Landa Jonathan , McAndrew Philomena F. , Modi Shanu , Morris Michael J. , Novosiadly Ruslan , Rathkopf Dana E. , Sanford Rachel , Chapman Sonya C. , Tate Courtney M. , Yu Danni , Wong Phillip , McArthur Heather L.
Published: April 2023

Summary of changes in immune cell subsets from baseline to Cycle 1 Day 8 after LY3022855 treatment.
Supplementary Text from Single-Cell–Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response
Authors: Braun Rüdiger , Anthuber Lena , Hirsch Daniela , Wangsa Darawalee , Lack Justin , McNeil Nicole E. , Heselmeyer-Haddad Kerstin , Torres Irianna , Wangsa Danny , Brown Markus A. , Tubbs Anthony , Auslander Noam , Gertz E. Michael , Brauer Philip R. , Cam Margaret C. , Sackett Dan L. , Habermann Jens K. , Nussenzweig Andre , Ruppin Eytan , Zhang Zhongqiu , Rosenberg Daniel W. , Ried Thomas
Published: April 2023

Supplementary text
Figure S7 from Single-Cell–Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response
Authors: Braun Rüdiger , Anthuber Lena , Hirsch Daniela , Wangsa Darawalee , Lack Justin , McNeil Nicole E. , Heselmeyer-Haddad Kerstin , Torres Irianna , Wangsa Danny , Brown Markus A. , Tubbs Anthony , Auslander Noam , Gertz E. Michael , Brauer Philip R. , Cam Margaret C. , Sackett Dan L. , Habermann Jens K. , Nussenzweig Andre , Ruppin Eytan , Zhang Zhongqiu , Rosenberg Daniel W. , Ried Thomas
Published: April 2023

SUPPLEMENTARY FIGURE S7: Pre-ranked GSEA analysis for the most resistant (1G10) and most sensitive (2F4) SCDCL vs the parental cell population.
Supplementary Figure S2 from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Authors: Autio Karen A. , Klebanoff Christopher A. , Schaer David , Kauh John Sae Wook , Slovin Susan F. , Adamow Matthew , Blinder Victoria S. , Brahmachary Manisha , Carlsen Michelle , Comen Elizabeth , Danila Daniel C. , Doman Thompson N. , Durack Jeremy C. , Fox Josef J. , Gluskin Jill S. , Hoffman David M. , Kang Suhyun , Kang Praneet , Landa Jonathan , McAndrew Philomena F. , Modi Shanu , Morris Michael J. , Novosiadly Ruslan , Rathkopf Dana E. , Sanford Rachel , Chapman Sonya C. , Tate Courtney M. , Yu Danni , Wong Phillip , McArthur Heather L.
Published: April 2023

Time plots of circulating levels of interleukin-34
Figure S3 from Single-Cell–Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response
Authors: Braun Rüdiger , Anthuber Lena , Hirsch Daniela , Wangsa Darawalee , Lack Justin , McNeil Nicole E. , Heselmeyer-Haddad Kerstin , Torres Irianna , Wangsa Danny , Brown Markus A. , Tubbs Anthony , Auslander Noam , Gertz E. Michael , Brauer Philip R. , Cam Margaret C. , Sackett Dan L. , Habermann Jens K. , Nussenzweig Andre , Ruppin Eytan , Zhang Zhongqiu , Rosenberg Daniel W. , Ried Thomas
Published: April 2023

SUPPLEMENTARY FIGURE S3: Genome-scale copy number variants (CNV) and b-allele patterns with whole exome sequencing (WES).
Figure S2 from Single-Cell–Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response
Authors: Braun Rüdiger , Anthuber Lena , Hirsch Daniela , Wangsa Darawalee , Lack Justin , McNeil Nicole E. , Heselmeyer-Haddad Kerstin , Torres Irianna , Wangsa Danny , Brown Markus A. , Tubbs Anthony , Auslander Noam , Gertz E. Michael , Brauer Philip R. , Cam Margaret C. , Sackett Dan L. , Habermann Jens K. , Nussenzweig Andre , Ruppin Eytan , Zhang Zhongqiu , Rosenberg Daniel W. , Ried Thomas
Published: April 2023

SUPPLEMENTARY FIGURE S2: Morphology and growth kinetics of SCDCLs, Comet Assay and lollipop diagram of CTNNB1.
Figure S1 from Single-Cell–Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response
Authors: Braun Rüdiger , Anthuber Lena , Hirsch Daniela , Wangsa Darawalee , Lack Justin , McNeil Nicole E. , Heselmeyer-Haddad Kerstin , Torres Irianna , Wangsa Danny , Brown Markus A. , Tubbs Anthony , Auslander Noam , Gertz E. Michael , Brauer Philip R. , Cam Margaret C. , Sackett Dan L. , Habermann Jens K. , Nussenzweig Andre , Ruppin Eytan , Zhang Zhongqiu , Rosenberg Daniel W. , Ried Thomas
Published: April 2023

SUPPLEMENTARY FIGURE S1: aCGH of the parental cell line WHrec1 and experimental workflow
Supplementary Data from Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study
Authors: Shi Yuankai , Cai Qiqing , Jiang Yu , Huang Gang , Bi Minghong , Wang Baocheng , Zhou Yuhong , Wang Guowen , Ying Hongyan , Tao Zhiwei , Shi Chunmei , Guo Qian , Gao Chao
Published: April 2023

Supplementary data-clean
Figure S5 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
Authors: Cai Jinhua , Zheng Junjiong , Shen Jun , Yuan Zhiyong , Xie Mingwei , Gao Miaomiao , Tan Hongqi , Liang Zhongguo , Rong Xiaoming , Li Yi , Li Honghong , Jiang Jingru , Zhao Huiying , Argyriou Andreas A. , Chua Melvin L.K. , Tang Yamei
Published: April 2023

Figure S5. Model comparisons using ROC curve analyses.
Supplementary Table S3 from Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to Immunotherapy
Authors: Klein Sebastian , Quaas Alexander , Noh Ka-Won , Cartolano Maria , Abedpour Nima , Mauch Cornelia , Quantius Jennifer , Reinhardt Hans Christian , Buettner Reinhard , Peifer Martin , Helbig Doris
Published: April 2023

Quality measurements of exome sequencing
Figure S1 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
Authors: Cai Jinhua , Zheng Junjiong , Shen Jun , Yuan Zhiyong , Xie Mingwei , Gao Miaomiao , Tan Hongqi , Liang Zhongguo , Rong Xiaoming , Li Yi , Li Honghong , Jiang Jingru , Zhao Huiying , Argyriou Andreas A. , Chua Melvin L.K. , Tang Yamei
Published: April 2023

Figure S1. Recruitment pathway for patients in this study.
Supplementary Figure legends from Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to Immunotherapy
Authors: Klein Sebastian , Quaas Alexander , Noh Ka-Won , Cartolano Maria , Abedpour Nima , Mauch Cornelia , Quantius Jennifer , Reinhardt Hans Christian , Buettner Reinhard , Peifer Martin , Helbig Doris
Published: April 2023

Supplementary Figure legends
Figure S5 from Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to Immunotherapy
Authors: Klein Sebastian , Quaas Alexander , Noh Ka-Won , Cartolano Maria , Abedpour Nima , Mauch Cornelia , Quantius Jennifer , Reinhardt Hans Christian , Buettner Reinhard , Peifer Martin , Helbig Doris
Published: April 2023

Figure S5
Supplementary Table S6 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Univariate and multivariate logistic regression analysis for risk of having NSCLC in Early Stages (n=75)
Supplementary Table S4 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Gene Methylation Detection, Sensitivity, Specificity Using Detectable vs. Non-detectable cutoff in NSCLC early stages
Supplementary Data from Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma
Authors: Bassaganyas Laia , Pinyol Roser , Esteban-Fabró Roger , Torrens Laura , Torrecilla Sara , Willoughby Catherine E. , Franch-Expósito Sebastià , Vila-Casadesús Maria , Salaverria Itziar , Montal Robert , Mazzaferro Vincenzo , Camps Jordi , Sia Daniela , Llovet Josep M.
Published: April 2023

Supplementary Table 4
Supplementary Table S11 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Univariate and multivariate logistic regression analysis for risk of having NSCLC in Black (n=38)
Supplementary Figure Legends from Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1–Expressing Tumors Compared to Normal Murine Lymphoid Tissue
Authors: Giesen Danique , Broer Linda N. , Lub-de Hooge Marjolijn N. , Popova Irina , Howng Bruce , Nguyen Margaret , Vasiljeva Olga , de Vries Elisabeth G.E. , Pool Martin
Published: April 2023

Figure legends for Figure S1-S6.
Supplementary Table S1 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Primers and probes of qMSP for Urine and Plasma samples
Figure S7 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Figure S7
Figure S4 from Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1–Expressing Tumors Compared to Normal Murine Lymphoid Tissue
Authors: Giesen Danique , Broer Linda N. , Lub-de Hooge Marjolijn N. , Popova Irina , Howng Bruce , Nguyen Margaret , Vasiljeva Olga , de Vries Elisabeth G.E. , Pool Martin
Published: April 2023

PET imaging and biodistribution in syngeneic MC38 tumor-bearing mice.
Figure S6 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Figure S6
Figure S3 from Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1–Expressing Tumors Compared to Normal Murine Lymphoid Tissue
Authors: Giesen Danique , Broer Linda N. , Lub-de Hooge Marjolijn N. , Popova Irina , Howng Bruce , Nguyen Margaret , Vasiljeva Olga , de Vries Elisabeth G.E. , Pool Martin
Published: April 2023

In vivo quantification of â�¸â�¹Zr-CX-072, â�¸â�¹Zr-PbCtrl and â�¸â�¹Zr-CX-075 PET imaging.
Figure S2 from Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1–Expressing Tumors Compared to Normal Murine Lymphoid Tissue
Authors: Giesen Danique , Broer Linda N. , Lub-de Hooge Marjolijn N. , Popova Irina , Howng Bruce , Nguyen Margaret , Vasiljeva Olga , de Vries Elisabeth G.E. , Pool Martin
Published: April 2023

Ex vivo biodistribution with escalating protein dose of â�¸â�¹Zr-CX-072, â�¸â�¹Zr-PbCtrl and â�¸â�¹Zr-CX-075.
Supplementary Data from Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab
Authors: Frerichs Kristine A. , Broekmans Marloes E.C. , Marin Soto Jhon A. , van Kessel Berris , Heymans Martijn W. , Holthof Lisa C. , Verkleij Christie P.M. , Boominathan Rengasamy , Vaidya Bhavesh , Sendecki Jocelyn , Axel Amy , Gaudet Francois , Pillarisetti Kodandaram , Zweegman Sonja , Adams Homer C. , Mutis Tuna , van de Donk Niels W.C.J.
Published: April 2023

Supplemental Methods; Supplemental Figure legends; Supplemental Table 1; Figure S1, S2, S3, S4, S5, S6, S7, S8 and S9
Supplementary Tables S1-S8 (clean version) from Clinical Outcome–Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma
Authors: Dai Wei , Chung Dittman Lai-Shun , Chow Larry Ka-Yue , Yu Valen Zhuoyou , Lei Lisa Chan , Leong Merrin Man-Long , Chan Candy King-Chi , Ko Josephine Mun-Yee , Lung Maria Li
Published: April 2023

Table S1: Clinical parameters for the HK-3 cohort for targeted sequencing (N=402);Table S2: Sample size estimation and power calculation for study cohorts;Table S3: Mutational signatures and clinical parameters in primary NPC (N=178);Table S4: All the pathogenic germline and somatic alterations at BRCA2 (NM_000059) detected in NPC (N=216);Table S5: Germline and somatic alterations at the selected DNA damage and repair genes in 216 NPC cases for the genes with differential expression and SCNAs in NPC;Table S6: Germline rare variants detected at BRCA2 (NM_000059) in the HK-3 cohort (N=402);Table S7: Association of BRCA2 germline rare variants with clinical parameters in the HK-3 cohort (N=402);Table S8: Differentially methylated CpG sites between signature 3-positive and -negative cases
Supplementary Legend from Clinical Outcome–Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma
Authors: Dai Wei , Chung Dittman Lai-Shun , Chow Larry Ka-Yue , Yu Valen Zhuoyou , Lei Lisa Chan , Leong Merrin Man-Long , Chan Candy King-Chi , Ko Josephine Mun-Yee , Lung Maria Li
Published: April 2023

Supplementary Legend
Supplemental Figure 3 from CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Authors: Leuci Valeria , Donini Chiara , Grignani Giovanni , Rotolo Ramona , Mesiano Giulia , Fiorino Erika , Gammaitoni Loretta , D'Ambrosio Lorenzo , Merlini Alessandra , Landoni Elisa , Medico Enzo , Capellero Sonia , Giraudo Lidia , Cattaneo Giulia , Iaia Ilenia , Pignochino Ymera , Basiricò Marco , Vigna Elisa , Pisacane Alberto , Fagioli Franca , Ferrone Soldano , Aglietta Massimo , Dotti Gianpietro , Sangiolo Dario
Published: April 2023

Phenotypic characterization of CSPG4-CAR.CIK and CSPG4-CAR.T
Supplementary Figure S3 from Clinical Outcome–Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma
Authors: Dai Wei , Chung Dittman Lai-Shun , Chow Larry Ka-Yue , Yu Valen Zhuoyou , Lei Lisa Chan , Leong Merrin Man-Long , Chan Candy King-Chi , Ko Josephine Mun-Yee , Lung Maria Li
Published: April 2023

Figure S3: COSMIC signature contributions. Annotation of the signature is obtained from the Cosmic database (https://cancer.sanger.ac.uk/cosmic/signatures_v2).
Supplementary Figure S2 from Clinical Outcome–Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma
Authors: Dai Wei , Chung Dittman Lai-Shun , Chow Larry Ka-Yue , Yu Valen Zhuoyou , Lei Lisa Chan , Leong Merrin Man-Long , Chan Candy King-Chi , Ko Josephine Mun-Yee , Lung Maria Li
Published: April 2023

Figure S2: The factorization rank plot estimated by the R package NMF.
Supplementary Figure S1 from Clinical Outcome–Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma
Authors: Dai Wei , Chung Dittman Lai-Shun , Chow Larry Ka-Yue , Yu Valen Zhuoyou , Lei Lisa Chan , Leong Merrin Man-Long , Chan Candy King-Chi , Ko Josephine Mun-Yee , Lung Maria Li
Published: April 2023

Figure S1: Study workflow.